![Gorjan Hrustanovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gorjan Hrustanovic
Directeur/Membre du Conseil chez
KYMERA THERAPEUTICS, INC.
Fortune : 13 M $ au 30/06/2026
Profil
Dr. Gorjan Hrustanovic is an Independent Director at Kymera Therapeutics, Inc. and an Independent Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Kymera Therapeutics, Inc., Olema Pharmaceuticals, Inc., Forward Therapeutics, Inc., Plexium, Inc. and BVF Partners LP.
Dr. Hrustanovic was previously employed as a Member-Observer Board by 4D Molecular Therapeutics, Inc. and an Independent Director by Rain Oncology, Inc. He also served on the board at Nimbus Therapeutics LLC.
He received his undergraduate degree from the University of California San Diego and a doctorate degree from The University of California, San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 116 190 ( 0,14% ) | 13 M $ | 30/06/2026 | |
| 18/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Gorjan Hrustanovic
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2020 |
| OLEMA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/07/2018 |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Directeur/Membre du Conseil | - |
Forward Therapeutics, Inc.
 Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Directeur/Membre du Conseil | - |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Directeur/Membre du Conseil | - |
Anciens postes connus de Gorjan Hrustanovic
| Sociétés | Poste | Fin |
|---|---|---|
| RAIN ONCOLOGY INC. | Directeur/Membre du Conseil | 25/01/2024 |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Directeur/Membre du Conseil | - |
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Gorjan Hrustanovic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Finance |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Forward Therapeutics, Inc.
Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Health Technology |
Choisissez Zonebourse 
